ArticleCureus2026

A Randomized, Multicenter Study Evaluating the Efficacy, Safety and Tolerability of Dapagliflozin + Gliclazide Fixed Dose Combination Over Dapagliflozin Monotherapy in Type 2 Diabetes Mellitus Patients Inadequately Controlled on Metformin Monotherapy.

Suhas G Erande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.